Gene · 100187828
Papers1,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hb A2-Guangxi [δ79 (EF3) Asp→Asn, HBD: C.238G > A] and polyA + 70 (HBD: C.*200G > A): Two Novel δ-Globin Gene Mutations Identified in a Chinese Family. | Hemoglobin | 2024 | 39175389 | PubTator, text mining | PubMed |
| Specific multivalent molecules boost CRISPR-mediated transcriptional activation. | Nat Commun | 2024 | 39174527 | PubTator, text mining | PubMed |
| Analysis of prefrontal cerebral blood volume and flow changes in ESKD patients undergoing hemodialysis using functional near-infrared spectroscopy. | Ren Fail | 2024 | 39135525 | PubTator, text mining | PubMed |
| Prevalence and Regional Distribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program". | J Epidemiol Glob Health | 2024 | 39073533 | PubTator, text mining | PubMed |
| Detection of HbD Punjab Trait in Saurashtra Region of Gujarat by HPLC Method. | Indian J Clin Biochem | 2024 | 39005868 | PubTator, text mining | PubMed |
| Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues. | Sci Adv | 2024 | 38996032 | PubTator, text mining | PubMed |
| Evaluation of cross-cultural adaptation and validation of the Persian version of the critical thinking disposition scale: methodological study. | BMC Nurs | 2024 | 38978026 | PubTator, text mining | PubMed |
| Spatial-temporal evolution of technology flows in China's Beijing-Tianjin-Hebei region: Patent transfer networks 2003-2021. | PLoS One | 2024 | 38935773 | PubTator, text mining | PubMed |
| Spatiotemporal expression and control of haemoglobin in space. | Nat Commun | 2024 | 38862545 | PubTator, text mining | PubMed |
| The heparin-binding domain of VEGF165 directly binds to integrin αvβ3 and VEGFR2/KDR D1: a potential mechanism of negative regulation of VEGF165 signaling by αvβ3. | Front Cell Dev Biol | 2024 | 38803393 | PubTator, text mining | PubMed |
| Interference of hemoglobin variants with HbA1c measurements by six commonly used HbA1c methods. | Lab Med | 2024 | 38801245 | PubTator, text mining | PubMed |
| Detection of 13 Novel Variants and Investigation of Mutation Distribution by Next Generation Sequencing in Hemoglobinopathies: A Single Center Experience. | Indian J Hematol Blood Transfus | 2024 | 38708170 | PubTator, text mining | PubMed |
| Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing. | Sci Rep | 2024 | 38693200 | PubTator, text mining | PubMed |
| Molecular epidemiology and hematological profiles of hemoglobin variants in southern Thailand. | Sci Rep | 2024 | 38649425 | PubTator, text mining | PubMed |
| Proceedings of the CIMAGO Congress - Environment, Genetics and Oncobiology in the 21st Century - Challenges and Opportunities. | Medicine (Baltimore) | 2024 | 38579039 | PubTator, text mining | PubMed |
| Wide spectrum of novel and rare hemoglobin variants in the multi-ethnic Indian population: A review. | Int J Lab Hematol | 2024 | 38504512 | PubTator, text mining | PubMed |
| Bioinformatics analysis characterizes immune infiltration landscape and identifies potential blood biomarkers for heart transplantation. | Transpl Immunol | 2024 | 38499050 | PubTator, text mining | PubMed |
| A New δ-Globin Gene Variant: Hb A2-Yulin [δ46(CD5)Gly→Arg,HBD: C.139G > A]. | Hemoglobin | 2024 | 38450437 | PubTator, text mining | PubMed |
| Human beta defensin 3 knockdown inhibits the proliferation and migration of airway smooth muscle cells through regulating the PI3K/AKT signaling pathway. | Mol Immunol | 2024 | 38422885 | PubTator, text mining | PubMed |
| Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. | Nat Commun | 2024 | 38280848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100187828/papers?page=7